Dr. Jason McKeown is a UK-trained medical doctor with a PhD in Non-invasive Neurostimulation. Through his work in the field of neuroscience and interest in advanced technology, he believes there is a better way to treat diseases affecting the lives of people worldwide. His dedication to advancing medical technology, combined with his deep understanding of diabetes, anxiety, and insomnia, has positioned him as a trailblazer in the field.

In 2016, as a visiting scholar at the University of California, San Diego, Center for Brain & Cognition, Dr. McKeown researched neuroscience and neuromodulation in partnership with Professor V.S. Ramachandran. It was in this lab that the technology behind the Modius products was born. After years of research and development, Dr. McKeown led the Neurovalens team through a successful study into the effectiveness of the Modius Sleep device on the treatment of chronic insomnia, resulting in Medical Device Regulatory Approval via FDA 510(k) clearance in October 2023. In March 2024, Neurovalens also received FDA clearance for Modius Stress, a treatment for anxiety.

In April 2024, Dr. McKeown was appointed visiting scholar at the University of California, San Diego (UCSD), in the Department of Psychiatry. Dr. McKeown is a member of the General Medical Council and has worked within the National Health Service (NHS) in the UK. Dr McKeown is also a member of the Society for Neuroscience, the Royal College of Emergency Medicine, the Association of British Neurologists, the Royal College of Physicians and The Society for Neuroscience.